RC25 Pill - yellow round, 7mm
Pill with imprint RC25 is Yellow, Round and has been identified as Donepezil Hydrochloride 5 mg. It is supplied by Ranbaxy Pharmaceuticals Inc.
Donepezil is used in the treatment of Alzheimer's Disease and belongs to the drug class cholinesterase inhibitors. Risk cannot be ruled out during pregnancy. Donepezil 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RC25
Donepezil Hydrochloride
- Imprint
- RC25
- Strength
- 5 mg
- Color
- Yellow
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Cholinesterase inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ranbaxy Pharmaceuticals Inc.
- Inactive Ingredients
-
corn starch,
hydroxypropyl cellulose,
hypromelloses,
ferric oxide yellow,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
sodium starch glycolate type A potato,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 63304-0128 | Ranbaxy Pharmaceuticals Inc. |
| 68084-0477 (Discontinued) | Amerisource Health Services |
| 63739-0667 (Discontinued) | McKesson Packaging Services |
Related images for "RC25"
More about donepezil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (119)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: cholinesterase inhibitors
Patient resources
- Donepezil drug information
- Donepezil skin patch
- Donepezil (Oral) (Advanced Reading)
- Donepezil (Transdermal) (Advanced Reading)
- Donepezil 23 mg Tablets
Other brands
Aricept, Adlarity, Aricept ODT
Professional resources
- Donepezil monograph
- Donepezil (FDA)
- Donepezil ER Tablets (FDA)
- Donepezil Orally Disintegrating Tablet (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
